NIP292 tablet
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
The National Institutes of Pharmaceutical R&D Co. Ltd, China
Overview
NIP292 tablet is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
NIP292 tablet clinical trials
Explore related
Medical disclaimer. This page summarizes research about NIP292 tablet for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.